跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 364 条关于
“sacituzumab govetecan”
全部
364
临床试验
240
药物
16
机构
0
资讯
108
4个月前
Breast Cancer Drug Shows Promise for Treatment-Resistant Uterine Cancer in Phase II Trial
去年
Gilead Withdraws Sacituzumab Govitecan's Bladder Cancer Approval After TROPiCS-04 Failure
去年
Gilead Sciences Advances Sacituzumab Govitecan Studies Across Multiple Cancer Types
2年前
Sacituzumab Govitecan Shows Promise in Second-Line Treatment of Extensive-Stage Small Cell Lung Cancer
2年前
Sacituzumab Govitecan Shows Promise in Advanced Urothelial Cancer After Immunotherapy
去年
Sacituzumab Govitecan Shows Promise in Heavily Pretreated HR+/HER2- Breast Cancer Patients
去年
Sacituzumab Govitecan Demonstrates Efficacy in HR+/HER2- Metastatic Breast Cancer
去年
Sacituzumab Govitecan Shows Promise in Treating Brain Metastases and Glioblastoma in Phase 0 Trial
去年
Phase 3 TROPiCS-04 Trial: Sacituzumab Govitecan Fails to Meet Survival Endpoints in Advanced Urothelial Cancer
去年
ADC Safety Management in mTNBC: Genetic Screening and Prophylactic Strategies Emerge for Sacituzumab Govitecan
第 1 页,共 11 页
上一页
下一页